Estado actual del tratamiento quirúrgico del cáncer de recto: evaluación preoperatoria y estadiaje
Palabras clave:
cáncer de rectoResumen
Artículo especial: capítulo 1 de la “Guía práctica para el tratamiento quirúrgico del cáncer de recto" del Grupo Gallego de Coloproctología y la Sociedad de Cirugía de Galicia
Descargas
Citas
1. Estimaciones de la incidencia del cancer en España, 2020. Red española de registros de cancer (REDECAN), 20212.
2. Las cifras del cancer en España 2022. Sociedad Española de Oncología Médica (SEOM), 2022. ISBN: 978-84-09-38029-9.
3. Vuik F. E., Nieuwenburg S. A., Bardou M., Lansdorp Vogelaar I., Dinis Ribeiro M., Bento M. J., et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut. 2019; 68:1820-6. Doi: 10.1136/gutjnl-2018-317592.
4. United European Gastroenteroloy. European Cancer Information System. European Commission 2018.
5. Wei T., Luo P., Zhang X., Zhu W., Zhang J. Comparison of the incidence of colorectal cancer in young adults between the USA and Europe. Gut. 2020; 69:1540-2. Doi: 10.1136/gutjnl-2019-319391.
6. Oxford Centre for Evidence-based Medicine (CEBM). Centre for Evidence Based Medicine-Levels of Evidence (March 2009). Dispoñible en: http://www.cebm.net/index.aspx?o=1025.
7. McMullen T. P., Easson A. M., Cohen Z., Swallow C. J. The investigation of primary rectal cancer by surgeons: current pattern of practice. Can J Surg. 2005; 48:19-26.
8. DʼSouza N., de Neree Tot Babberich MPM, d'Hoore A., Tiret E., Xynos E., et al. Definition of the Rectum: An International, Expert-based Delphi Consensus. Ann Surg. 2019; 270:955-9. Doi: 10.1097/SLA.0000000000003251.
9. Codina Cazador A., Biondo S., Espín Basany E., Enríquez Navascues J. M., García Granero E., Roig Vila J. V., et al. A teaching project on rectal cancer and concentration of procedures: a comparison of oncological results between Catalonia and the rest of autonomous communities. Rev. Esp. Enferm. Dig. 2019; 111:519-29. Doi: 10.17235/reed.2019.5901/2018.
10. Aquina C. T., Probst C. P., Becerra A. Z., Iannuzzi J. C., Kelly K. N., Hensley B. J., et al. High volume improves outcomes: The argument for centralization of rectal cancer surgery. Surgery. 2016; 159:736-48. Doi: 10.1016/j.surg.2015.09. 021.
11. Wasserman M. A., McGee M. F., Helenowski I. B., Halverson Al, Boller A. M., Stryker S. J. The anthropometric definition of the rectum is highly variable. Int J Colorectal Dis. 2016; 31:189-95. Doi: 10.1007/s00384-015-2458-5.
12. Wlodarczyk J., Kim D., Finney C., Gupta A., Cannom R., Duldulao M. Inking outside the box: systematic review on the utility of tattooing lesions in rectal cancer. Int J Colorectal Dis. 2022. Doi: 10.1007/s00384-022-04239-e.
13. Attenberger U. I., Winter J., Harder F. N., Burkholder I., Dinter D., Kaltschmidt S., et al. Height of Rectal Cancer: A Comparison between Rectoscopic and Different MRI Measurements. Gastroenterol Res Pract. 2020 28; 2020:2130705. Doi: 10.1155/2020/2130705.
14. Wilkinson N. Management of Rectal Cancer. Surg Clin North Am. 2020; 100:615-28. Doi: 10.1016/j.suc.2020.02.014.
15. Glynne Jóns R., Wyrwicz L., Tiret E., Brown G., Rödel C., Cervantes A., et al. ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnose, treatment and follow-up. Ann Oncol. 2018; 29 (Suppl 4):iv263. Doi: 10.1093/annonc/mdy161. Erratum for: Ann Oncol. 2017; 28(suppl_4):iv22-iv40.
16. Nakamura E., Shida D., Tanabe T., Takamizawa E., Imaizumi J., Ahiko E., et al. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer. Cancer Med. 2020; 9:653-62. Doi: 10.1002/cam4.2758.
17. Kim C. W., Yu C. S., Yang S. S., Kim K. H., Yoon Y. S., Yoon SN, et al. Clinical significance of pre- to post-chemoradiotherapy s-CEA redution cociente in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2011; 18: 3271-7. Doi: 10.1245/s10434-011-1740-1.
18. Park X. A., Le K. Y., Kim N. K., Baik S. H., Sohn S. K., Cho C. W. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol. 2006; 13:645-50. Doi: 10.1245/ASO.2006.03.090.
19. Steele G. Jr., Ellenberg S., Ramming K., O'Connell M., Moertel C., Lessner H., et al. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg. 1982; 196:162-9. Doi: 10.1097/00000658-198208000-00008.
20. Tarantino I., Warschkow R., Worni M., Merati Kashani K., Köberle D., Schmied B. M., et al., Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer. 2012; 107:266-74. Doi: 10.1038/bjc.2012.267.
21. Le J. H., Kim D. Y., Kim S. H., Cho H. M., Shim B. Y., Kim T. H., et al. Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12. Radiother Oncol. 2015; 116:202-8. Doi: 10.1016/j.radonc.2015.07.049.
22. Probst C. P., Becerra A. Z., Aquina C. T., Tejani M. A., Hensley B. J., González M. G., Noyes K., Monson J. R., Fleming F. J. Watch and Wait? Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer. J Gastrointest Surg. 2016; 20:43-52; doi: 10.1007/s11605-015-2987-9.
23. Nicholson B. D., Shinkins B., Pathiraja I., Roberts N. W., James T. J., Mallett S, et al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev. 2015 (12):CD011134. Doi: 10.1002/14651858. CD011134.
24. Hangge P. T., Calderon E., Habermann E. B., Glasgow A. E., Mishra N. Primary Colorectal Lymphoma: Institutional Experience and Review of a National Database. Dis Colon Rectum. 2019; 62(10):1167-76. Doi: 10.1097/DCR.0000000000001279.
25. Hatch K. F., Blanchard D. K., Hatch G. F. 3rd, Wertheimer Hatch L., Davis G. B., Foster R. S. Jr, et al. Tumors of the rectum and anal canle. World J Surg. 2000; 24:437-43. Doi: 10.1007/s0026899 10069.
26. Chen J. S., Hsieh P. S., Hung S. Y., Tang R., Tsai W. S., Changchien C. R., et al. Clinical significance of signet ring cell rectal carcinoma. Int J Colorectal Dis. 2004; 19:102-7. Doi: 10.1007/s00384-003-0515-e.
27. Davila R. E., Rajan E., Adler D., Hirota W. K., Jacobson B. C., Leighton J. A., et al. ASGE guideline: the role of endoscopy in the diagnose, staging, and management of colorectal cancer. Gastrointest Endosc. 2005; 61:1-7. Doi: 10.1016/s0016-5107(04)02391-0.
28. Halligan S., Dadswell E., Wooldrage K., Wardle J., von Wagner C., Lilford R., Yao G. L., Zhu S., Atkin W. Computed tomographic colonography compared with colonoscopy or barium enema for diagnose of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials). Health Technol Assess. 2015; 19:1-134. Doi: 10.3310/hta19540. PMID: 26198205; PMCID: PMC4781284.
29. Halligan S., Altman D. G., Taylor S. A., Mallett S., Deeks J. J., Bartram C. I., et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology. 2005 ; 237:893-904. Doi: 10.1148/radiol.2373050176.
30. Mulhall B. P., Veerappan G. R., Jackson J. L. Meta-analysis: computed tomographic colonography. Ann Intern Med. 2005 ; 142:635-50. Doi: 10.7326/0003-4819-142-8-200504190-00013.
31. Rex D. K., Kahi C. J., Levin B., Smith R. A., Bond J. H., Brooks D., Burt R. W., et al. American Cancer Society; US Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after 55 cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006; 130:1865-71. Doi: 10.1053/j.gastro.2006.03.013.
32. UICC. TNM Classification of Malignant Tumours 8th edn. New York John Wiley & Sons, Ltd; 2017.
33. Weiser M. R. AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol. 2018; 25:1454-5. Doi: 10.1245/s10434-018-6462-1.
34. Fokas E., Ströbel P., Fietkau R., Ghadimi M., Liersch T., Grabenbauer G. G., et al. Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. J Natl Cancer Inst. 2017; 109. Doi: 10.1093/jnci/djx095. PMID: 29206996.
35. Benson A. B., Venook A. P., Al-Hawary M. M., Arain M. A., Chen Y. J., Ciombor K. K., et al. NCCN Guidelines Insights: Rectal Cancer, Version 6.2020: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw. xullo de 2020; 18: 806-15.
36. Poon F. W., McDonald A., Anderson J. H., Duthie F., Rodger C., McCurrach G., et al. Accuracy of thin section magnetic resonance using phased-array pelvic coil in predicting the T-staging of rectal cancer. Eur J Radiol. 2005; 53:256-62. Doi: 10.1016/j.ejrad.2004.03.011.
37. Bruening W., Sullivan N., Paulson E. C., Zafar H., Mitchell M., Treadwell J., Schoelles K. Imaging Tests for the Staging of Colorectal Cancer [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Sep. Report Non.: 14-EHC046-EF. PMID: 2534022.
38. Lahaye M. J., Engelen S. M., Nelemans P. J., Beets G. L., van de Velde C. J., van Engelshoven JM, Beets-Tan RG. Imaging for predicting the risk factors--the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR. 2005; 26:259-68. Doi: 10.1053/j.sult.2005.04.005. PMID: 16152740.
39. Purkayastha S., Tekkis P. P., Athanasiou T., Tilney H. S., Darzi A. W., Heriot A. G. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis. 2007; 9: 402-11. Doi: 10.1111/j.1463-1318.2006. 01104.x.
40. Brown G., Daniels I. R. Preoperative staging of rectal cancer: the MERCURY research project. Recent Results. Cancer Res. 2005; 165:58-74. Doi: 10.1007/3-540-27449-9_8.
41. Li X. T., Zhang X. Y., Sun Y. S., Tang L., Cao K. Evaluating rectal tumor staging with magnetic resonance imaging, computed tomography, and endoluminal ultrasound: A meta-analysis. Medicine (Baltimore). 2016; 95:e5333. Doi: 10.1097/MD.0000000000005333. PMID: 27858916; PMCID: PMC5591164.
42. Balch G. C., De Meo A., Guillem J. G. Modern management of rectal cancer: a 2006update. World J Gastroenterol. 2006; 12: 3186-95. Doi: 10.3748/wjg.v12.i20.3186.
43. Nordholm Carstensen A. Pulmonary nodules and metastases in colorectal cancer. Dan Med J. 2016; 63(1):B5190. PMID: 26726908.
44. Choi D. J., Kwak J. M., Kim J., Woo S. U., Kim S. H. Preoperative chest computerized tomography in patients with locally advanced mid or lower rectal cancer: its role in staging and impact on treatment strategy. J Surg Oncol. 2010; 102(6):588-92. Doi: 10.1002/jso.21651.
45. Mainenti P. P., Mancini M., Mainolfi C., Camera L., Maurea S., Manchia A., et al. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging. 2010; 35:511-21. Doi: 10.1007/s00261-009-9555-2.
46. Adam R., de Gramont A., Figueras J., Kokudo N., Kunstlinger F., Loyer E., et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015; 41:729-41. Doi: 10.1016/j.ctrv.2015.06.006.
47. Tsili A. C., Alexiou G., Naka C., Argyropoulou M. I. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis. Acta Radiol. 2021; 62:302-12. Doi: 10.1177/0284185120925481.
48. Schulz A., Viktil E., Godt J. C., Johansen C. K., Dormagen J. B., Holtedahl J. E., Labori K. J., Bach-Gansmo T., Kløw N. E. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI. Acta Radiol. 2016; 57:1040-8. Doi: 10.1177/0284185115617349.
49. Cantwell C. P., Setty BN, Holalkere N., Sahani D. V., Fischman A. J., Blake M. A. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI. J Comput Assist Tomogr. 2008; 32:738-44. Doi: 10.1097/RCT.0b013e3181591d33.
50. Somashekhar S. P., Saklani A., Dixit J., Kothari J., Nayak S., et al. Clinical Robotic Surgery Association (India Chapter) and Indian rectal cancer expert group's practical consensus statements for surgical management of localized and locally advanced rectal cancer. Front Oncol. 2022; 12:1002530. Doi: 10.3389/fonc.2022.1002530.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2026 R López de los Reyes , A. Abril Banet , S. Núñez Fernández
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
